.png)
HB Takes the Lead in Airborne Cold Chain Logistics at LogiPharma
From April 8 to 10, LogiPharma Lyon 2025, the world's leading event for the healthcare supply chain, took place in France. HB TempCon Aviation, a subsidiary of Haier Biomedical, made an impact with its Active Temperature Controlled RKN container, which became a focal point of the exhibition.
The Active Temperature Controlled RKN Container recently received the first and only FAA Letter of Design Approval (LODA) in the Asia-Pacific region, successfully passing the airworthiness review by the US Federal Aviation Administration (FAA). This milestone allows vaccines and pharmaceuticals to enjoy "first class treatment" even at cruising altitudes.
Equipped with proprietary ACS (Air Circulation System) and ATC (Adaptive Temperature Control) technologies, this state-of-the-art container provides real-time monitoring, automatic regulation and intelligent control of internal temperature. It ensures consistent and precise thermal conditions throughout the journey, mastering the complexities of pharmaceutical air transport with confidence.
As well as being ideal for international pharmaceutical air transport, it is also suitable for cold chain logistics for a wide range of temperature-sensitive products, including vaccines, biologics, APIs and high-value perishables, making it suitable for a wide range of industries. Haier Biomedical continues to demonstrate its strength through relentless innovation and intelligent manufacturing. When it comes to protecting life and health around the world, we're all in.
